Liz Hewitt
Member of the Board
Oncology
Novo Nordisk
Denmark
Biography
Ms Hewitt has a BSc (Econ Hons) from the University College in London, UK, and qualified as a Chartered Accountant FCA in 1982. In her executive career she worked for Arthur Andersen & Co., Gartmore Investment Management Ltd, UK, Citicorp Venture Capital (now CVC), 3i Group and Smith & Nephew plc, UK. Ms Hewitt serves as a member of the boards of Savills plc, where she is also chairman of the audit committee, and Melrose Industries plc, where she is also chairman of the Melrose Audit Committee, both in the UK. Ms Hewitt also serves as an external member of the House of Lords Commission, UK, where she also chairs the audit committee. Ms Hewitt was first elected to the Board of Novo Nordisk A/S in 2012 and has most recently been re-elected in March 2017. Her term as a board member expires in March 2018.
Research Interest
Finanance , Clinical Pharmaceutics
